Predictors of low-level viremia in chronic hepatitis B and the efficacy of pegylated interferon-alpha: a real-world study.

Virol J · 2025 · PMC12619509 · PMID 41239341

Europe PMC DOI

hedged sentence

0.6840

closest p · 13.7× alpha

0.6840

boldest claim

The sentences

difference was apparentp = 0.684not close (p > 0.1)

49.4%, p = 0.001), although no notable difference was apparent at week 24(36.2% vs. 39.6%, p = 0.684) (Fig. 3 A).

also in 198 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.